BioAtla, Inc. (BCAB) Free Cash Flow
BioAtla, Inc. (BCAB) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | -$63.14M |
| 2022-12-31 | -$90.69M |
| 2023-12-31 | -$104.11M |
| 2024-12-31 | -$71.94M |
| 2025-12-31 | -$48.20M |
How BCAB compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| HRTX | Heron Therapeutics Inc. | -$27.91M |
| VERU | Veru Inc. | -$30.04M |
| ALDX | Aldeyra Therapeutics Inc. | -$33.35M |
| XBIT | XBiotech Inc. | -$40.21M |
| EOLS | Evolus Inc. | -$50.72M |
These are five companies in the same sector as BCAB with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BioAtla, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("BCAB", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BCAB | $1.55 | -2.52% | 0.01M |
| 3 | ||||
| 4 | ||||
| 5 |